QTXBライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 2月 2024 @ 03:37):

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States...

Stats
本日の出来高	50 000.00
平均出来高	1 292.00
時価総額	314 786
EPS	$-0.000780 ( 2022-11-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.400
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2012-05-25	Hirschman Shalom	Buy	150 000	Common Stock
2012-05-25	Fleming William H	Buy	300 000	Common Stock
2012-03-01	Abrams Michael S	Buy	0
2010-04-30	Pinco Robert G.	Buy	0
2010-04-30	Mooney Patrick T	Sell	0	Common Stock

INSIDER POWER
0.00
Last 43 transactions
Buy: 5 215 300 \| Sell: 826 250

QuantRx Biomedical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

QuantRx Biomedical 財務諸表

Annual	2022
収益:	$0
総利益:	$0 (0.00 %)
EPS:	$0

FY	2022
収益:	$0
総利益:	$0 (0.00 %)
EPS:	$0

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-0.0100

FY	2020
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-0.0100

Financial Reports:

No articles found.

QuantRx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.